Suppr超能文献

三叉神经痛的诊断、分类、病理生理学和治疗进展。

Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia.

机构信息

Department of Neurology, Danish Headache Center, Rigshospitalet, Glostrup, Denmark.

Pain Management Centre, National Hospital for Neurology and Neurosurgery, London, UK; Eastman Dental Hospital, UCLH NHS Foundation Trust, London, UK.

出版信息

Lancet Neurol. 2020 Sep;19(9):784-796. doi: 10.1016/S1474-4422(20)30233-7.

Abstract

Trigeminal neuralgia is a very painful neurological condition with severe, stimulus-evoked, short-lasting stabbing pain attacks in the face. The past decade has offered new insights into trigeminal neuralgia symptomatology, pathophysiology, and treatment, leading to a change in the classification of the condition. An accurate diagnosis is crucial because neuroimaging interpretation and clinical management differ among the various forms of facial pain. MRI using specific sequences should be a part of the diagnostic workup to detect a possible neurovascular contact and exclude secondary causes. Demonstration of a neurovascular contact should not be used to confirm a diagnosis but rather to facilitate surgical decision making. Carbamazepine and oxcarbazepine are drugs of first choice for long-term treatment, whereas microvascular decompression is the first-line surgery in medically refractory patients. Advances in neuroimaging techniques and animal models will provide further insight into the causes of trigeminal neuralgia and its pathophysiology. Development of more efficacious treatment options is highly warranted.

摘要

三叉神经痛是一种非常痛苦的神经疾病,面部会出现剧烈、刺激诱发、短暂发作的刺痛。过去十年,人们对三叉神经痛的症状、病理生理学和治疗有了新的认识,导致该病的分类发生了变化。准确的诊断至关重要,因为神经影像学解读和临床管理在各种形式的面部疼痛中有所不同。使用特定序列的 MRI 应该是诊断性检查的一部分,以检测可能的神经血管接触并排除继发性原因。神经血管接触的表现不应用于确认诊断,而应有助于手术决策。卡马西平和奥卡西平是长期治疗的首选药物,而微血管减压术是药物难治性患者的一线手术。神经影像学技术和动物模型的进步将为三叉神经痛的病因及其病理生理学提供进一步的认识。非常有必要开发更有效的治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验